Studi clinici su Linfoma nello stato di New York
42 studi su Linfoma cercano partecipanti presso sedi nello stato di New York.
Città nello stato di New York
- New York City33 studi
- Queens10 studi
- Greenburgh9 studi
- Staten Island8 studi
- New Rochelle7 studi
- Buffalo6 studi
- Rochester5 studi
Testo ufficiale dello studio (inglese)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07192471A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- Roswell Park Comprehensive Cancer Center, Buffalo
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07015242Epco, Zanu, Ritux for R/R FL or MZL
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06563596Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, East White Plains
- Memorial Sloan Kettering Cancer Center, New York
- e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT02974647Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT04301076Collection of Tissue Samples for Cancer Research
- Roswell Park Cancer Institute, Buffalo
In reclutamentoStudio osservazionale
2 Months · Tutti i sessi · Aggiornato il 16 set 2026 · NCT00900198Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- Cornell, New York
In reclutamentoFase 1
Età da 18 a 100 · Tutti i sessi · Aggiornato il 15 set 2026 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, New York
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT06137144CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Roswell Park Cancer Institute, Buffalo
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- e altri 1
In reclutamentoFase 1/2
12 Months – 21 Years · Tutti i sessi · Aggiornato il 11 set 2026 · NCT04870944Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Rochester
In reclutamentoFase 3
Età da 18 a 18 · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07509151A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Stony Brook Univ Cancer Ctr, Stony Brook
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06624085TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07082803A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Hematology Oncology Associates of Central New York, East Syracuse
- University of Rochester, Rochester
- Stony Brook University Hospital Cancer Center, Stony Brook
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06084936Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Roswell Park Comprehensive Cancer Center, Buffalo
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT05826535A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Memorial Sloan Kettering Suffolk- Commack (Limited protocol activities), Commack
- Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT05389293Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- New York Medical College, Valhalla
In reclutamentoFase 1/2
Età da 13 a 90 · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT06533579A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Roswell Park Comprehensive Cancer Center, Buffalo
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 ago 2026 · NCT07188558DALY II USA/ MB-CART2019.1 for DLBCL
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 lug 2026 · NCT04792489A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
- Memorial Sloan Kettering, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 lug 2026 · NCT07465835A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Call for Information (Investigational Site 0031), New York
In reclutamentoFase 1/2
6 Months – 17 Years · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT02332668CD4CAR for CD4+ Leukemia and Lymphoma
- Albert Einstein Health Network, New York
In reclutamentoFase 1
Età 12 e oltre · Tutti i sessi · Aggiornato il 24 giu 2026 · NCT03829540A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 giu 2026 · NCT05475925A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)
- Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 giu 2026 · NCT07137494Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 giu 2026 · NCT05663502Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
- Columbia University Irving Medical Center, New York
In reclutamentoFase 2
Età 15 e oltre · Tutti i sessi · Aggiornato il 27 mag 2026 · NCT06954805A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
- Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- e altri 1
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 26 mag 2026 · NCT07052916Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- University of Rochester, Rochester
- Stony Brook University Medical Center, Stony Brook
- e altri 1
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 18 mag 2026 · NCT01790152Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
In reclutamentoFase 2
Fino a 26 anni · Tutti i sessi · Aggiornato il 14 mag 2026 · NCT07566377CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Roswell Park Comprehensive Cancer Center, Buffalo
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 apr 2026 · NCT03328078Study of CAR-T Therapy in Older Patients
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoStudio osservazionale
Età 60 e oltre · Tutti i sessi · Aggiornato il 7 apr 2026 · NCT04300998A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Memorial Sloan Kettering, New York
In reclutamentoFase 2
Età da 18 a 66 · Tutti i sessi · Aggiornato il 17 mar 2026 · NCT06859424Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
- Icahn School of Medicine at Mount Sinai, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 mar 2026 · NCT06510361A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities), Commack
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 mar 2026 · NCT06698003Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- e altri 1
In reclutamentoStudio osservazionale
Età 18 e oltre · Donne · Aggiornato il 4 mar 2026 · NCT01788839BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 feb 2026 · NCT06854003ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
- Columbia University, New York
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 gen 2026 · NCT06693830Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- e altri 1
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Tutte le età · Tutti i sessi · Aggiornato il 23 gen 2026 · NCT00582621Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- Noyes Memorial Hospital/Myers Cancer Center, Dansville
- Northwell Health/Center for Advanced Medicine, Lake Success
- Highland Hospital, Rochester
- e altri 3
In reclutamentoFase 3Volontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 gen 2026 · NCT05006482CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
- Columbia University Irving Medical Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 nov 2025 · NCT06420089Umbilical Cord Blood Transplantation From Unrelated Donors
- Wilmot Cancer Institute, Rochester
In reclutamentoStudio osservazionale
2 Months – 75 Years · Tutti i sessi · Aggiornato il 10 ott 2025 · NCT03016806Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.